Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bloomfield Hills, MI
NPI
1316063274
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
43494 Woodward Ave, Suite 208
Bloomfield Hills, MI, 48302
Phone (248) 335-7740
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,232 services
Medicare patients, 2024
162
Average age 74
Drug cost, 2024
$1.8M
2,724 prescriptions
Company payments, 2025
$2,622
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anjana Myneni was code 99214 (office e&m - established), 348 times for 130 patients. In total Anjana Myneni billed 1,232 services in 19 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 348 | 130 | $91.83 | $32K |
| 83036 Blood Count | Office | 296 | 97 | $9.46 | $2,799 |
| 95251 Test - Miscellaneous | Office | 166 | 58 | $26.35 | $4,374 |
| 82947 Clinical Chemistry | Office | 145 | 60 | $3.85 | $558 |
| 99213 Office E&M - Established | Office | 73 | 20 | $69.62 | $5,082 |
| 99215 Office E&M - Established | Office | 44 | 18 | $137.38 | $6,045 |
| 82570 Clinical Chemistry | Office | 41 | 39 | $5.08 | $208 |
| 82044 Clinical Chemistry | Office | 41 | 39 | $6.11 | $251 |
| 99204 Office E&M - New | Office | 13 | 13 | $124.36 | $1,617 |
By year: 2022 $56K for 1,212 services; 2023 $54K for 1,200 services; 2024 $56K for 1,232 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 296 | 97 | $9.46 | $2,799 |
| 82947 Clinical Chemistry | 145 | 60 | $3.85 | $558 |
| 82044 Clinical Chemistry | 41 | 39 | $6.11 | $251 |
| 82570 Clinical Chemistry | 41 | 39 | $5.08 | $208 |
Medicare prescription drug claims, 2024
In 2024, the drug Anjana Myneni prescribed most often to Medicare patients was Metformin Hcl, with 253 prescriptions and refills. In total Anjana Myneni wrote 2,724 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 253 | 753 | 77 | $3,135 |
| Levothyroxine Sodium Generic | 227 | 666 | 65 | $3,258 |
| Jardiance Empagliflozin | 198 | 432 | 51 | $239K |
| Ozempic Semaglutide | 186 | 358 | 45 | $334K |
| Trulicity Dulaglutide | 152 | 287 | 33 | $274K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 149 | 411 | 71 | $18K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 121 | 386 | 49 | $23K |
| Mounjaro Tirzepatide | 110 | 163 | 21 | $170K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 90 | 262 | 42 | $10K |
| Humalog Kwikpen U-100 Insulin Lispro | 81 | 247 | 31 | $27K |
| Novolog Flexpen Insulin Aspart | 74 | 193 | 29 | $19K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 59 | 182 | 18 | $98K |
| Tresiba Flextouch U-200 Insulin Degludec | 53 | 142 | 17 | $76K |
| Cequr Simplicity Bolus Insulin Pump, 200 Unit | 46 | 58 | 13 | $25K |
| Tresiba Flextouch U-100 Insulin Degludec | 42 | 151 | 17 | $31K |
Brand drugs: 1,651 claims; generic drugs: 699 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anjana Myneni $2,622 ($2,622 in general payments such as food, travel and fees) from 31 companies. The largest payer was Mannkind Corporation with $313.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 16 | $313 |
| Novo Nordisk Inc NVO | 13 | $292 |
| Amgen Inc. AMGN | 18 | $252 |
| Radius Health, Inc. | 9 | $203 |
| Corcept Therapeutics CORT | 9 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $165 |
| CeQur Corporation | 1 | $142 |
| Madrigal Pharmaceuticals MDGL | 3 | $103 |
| Xeris Pharmaceuticals, Inc. | 5 | $97.73 |
| Lilly USA, LLC LLY | 6 | $95.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.